14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
PIII vs KORE: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
PIII Overall Winner
6-Pillar Tally: PIII 3 – 2 KORE (1 Tie)
Matrix Metrics: PIII 5 – 3 KORE
As of Nov 20, 2026, P3 Health Partners Inc. (PIII) is the stronger overall head-to-head candidate over KORE Group Holdings, Inc. (KORE) in the Tradestie Institutional Equity Comparison Engine, winning 5–3 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). PIII carries a Unified Composite Score of 38.6/100 (SELL) at $1.69 (N/M Forward P/E, -5.2% operating margin), whereas KORE carries 55.3/100 (HOLD) at $9.25 (N/M Forward P/E, -6.2% operating margin).
Composite vs. Pillar Nuance: While KORE currently prints a higher short-term Unified Composite Score (55.3/100 HOLD vs. PIII 38.6/100 SELL), PIII captures the overall institutional head-to-head verdict (5–3 matrix metrics and 3–2 across the 6 pillars) due to superior fundamental profitability (-5.2% vs. -6.2% operating margin) and revenue trajectory (+14.8% vs. -8.8% YoY).
Technical & Structure Timing Caution: PIII is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 21.1); meanwhile KORE trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 50.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Competes within the Medical Care Facilities value chain with $385.5M market capitalization and -5.2% operating margin.
OpEx & R&D Reinvestment14.6% of Rev ($227M)
90D Engineering Disclosures0 Published
KORE Moat ProfileCyclical / Execution-Driven Positioning
Telecom Services Operator
Competes within the Telecom Services value chain with $163.0M market capitalization and -6.2% operating margin.
OpEx & R&D Reinvestment62.7% of Rev ($175M)
90D Engineering Disclosures0 Published
Investor FAQ PIII vs KORE Key Questions & Quantitative Answers
As of Nov 20, 2026, P3 Health Partners Inc. (PIII) is the stronger overall head-to-head candidate over KORE Group Holdings, Inc. (KORE) in the Tradestie Institutional Equity Comparison Engine, winning 5–3 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). PIII carries a Unified Composite Score of 38.6/100 (SELL) at $1.69 (N/M Forward P/E, -5.2% operating margin), whereas KORE carries 55.3/100 (HOLD) at $9.25 (N/M Forward P/E, -6.2% operating margin). Composite vs. Pillar Nuance: While KORE currently prints a higher short-term Unified Composite Score (55.3/100 HOLD vs. PIII 38.6/100 SELL), PIII captures the overall institutional head-to-head verdict (5–3 matrix metrics and 3–2 across the 6 pillars) due to superior fundamental profitability (-5.2% vs. -6.2% operating margin) and revenue trajectory (+14.8% vs. -8.8% YoY). Technical & Structure Timing Caution: PIII is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 21.1); meanwhile KORE trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 50.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
PIII leads the Growth & Scale pillar: PIII posts +14.8% YoY revenue growth and +0.0% YoY earnings growth on $1.55B TTM revenue (9.4% gross margin, -5.2% operating margin), compared with KORE at -8.8% YoY revenue growth and +0.0% YoY earnings growth on $280M TTM revenue (56.5% gross margin, -6.2% operating margin). Across the 7-period historical trajectory (FY2019 to FY2025), PIII cumulative revenue shifted +873.3% while KORE shifted +70.6%. In operating R&D and SG&A reinvestment, PIII deploys 14.6% of Rev ($227M) (0 90-day corporate R&D disclosures) versus 62.7% of Rev ($175M) (0 disclosures) for KORE.
PIII screens cheaper on headline valuation multiples. PIII trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.4x EV/Revenue (-5.5% FCF margin), whereas KORE trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 1.5x EV/Revenue (3.9% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against PIII (-105.8% ROE) versus KORE (-336.9% ROE) capital efficiency.
In options market volatility and institutional positioning, PIII carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-0.87β · 132% Vol realized risk). By comparison, KORE carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-0.15β · 29% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.